Advances and difficulties associated with the therapy of chronic HCV infection

Abstract

The most important aspects associated with the therapy of chronic hepatitis C viral infection (HCV) using interferon-free therapy with DAA drugs (IFN-free DAA regimens) are mentioned. This therapy is very effective, safe, with minimum contraindications and adverse events.

We must also permanently remember some crucial principles accociated with this therapy: interaction with other medicaments, possibility of HBV reactivation and principles of care after successful treatment.

Keywords

• HCV infection
• HBV infection
• interferon-free therapy
• DAA drugs
• HBV reactivation